Cortexyme gathers M to fund efficacy study of antibiotic for Alzheimer’s Alzheimer’s disease startup Cortexyme was able to round up $76 million in funding for a potentially first-in-class treatment, while […]
Indivior’s legal challenges escalate with new Suboxone subpoena from California Already under fire from U.S. authorities and others, Indivior faces new legal scrutiny from officials in California. Source: Fierce Pharma […]
Biogen poaches Pfizer dealmaker Dan Karp for stepped-up M&A push Want to get serious about business development? Take a page from Pfizer’s playbook—and that’s exactly what Biogen is doing. On […]
Ambien made me racist? No way, Sanofi tells Roseanne, and its tweet goes viral The head of North American communications for Sanofi woke up Wednesday to the news that actress […]
Allergan puts women’s health, infectious disease units on the block Allergan may just be ready to take some analysts’ advice. The Dublin drugmaker has wrapped up its strategic review and […]
AzurRx brings on longtime drug developer James Pennington as CMO James Pennington has joined AzurRx BioPharma as its chief medical officer as the company aims to launch a phase 2 […]
Crescendo cuts psoriasis drug deal with China’s Zai Labs Just weeks after closing a $70 million second-round financing, U.K. biotech Crescendo Biologics has signed another partner for its slimline antibody-like […]
Allergan recalls sample packs of Taytulla contraceptive pills over packaging error Some U.S. women given a sample package of an Allergan birth control drug got more than they bargained for: […]
Roche’s Tecentriq grabs badly needed lung cancer win to keep Keytruda in its sights Looks like Merck’s Keytruda could get some company in the lung cancer chemo-combo department. On Monday, […]
EMA lays cornerstones for new Amsterdam headquarters The European Medicines Agency has begun laying the foundation for its new Amsterdam headquarters, aiming to finish construction by November 2019. Source: FierceMedicalDevices […]